AZTR vs PATH
Azitra Inc (AZTR) versus Uipath Inc (PATH) — a side-by-side from cached financials, not a winner call.
Azitra Inc (AZTR) is a biotechnology company listed on US.
Uipath Inc (PATH) is a software - infrastructure company listed on US.
Latest reported AZTR revenue for 2024-12-31 was $7.5K. Net income was -$9.0M. Revenue was down 98.9% from 2023-12-31 to 2024-12-31. AZTR currently screens at market cap $3.7M.
Latest reported PATH revenue for 2026-01-31 was $1.61B. Net income was $282.3M. Revenue was up 12.7% from 2025-01-31 to 2026-01-31. PATH currently screens at market cap $6.07B and trailing P/E 19.4.
AZTR currently screens at market cap $3.7M. PATH currently screens at market cap $6.07B and trailing P/E 19.4.
Not investment advice. Open the AZTR and PATH stock pages for the full models.
Not investment advice.